HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums

This article was originally published in The Rose Sheet

Executive Summary

Net revenues advanced 22% to $71 mil. in the first quarter, attributed to a 29% increase in prestige products sales, Inter Parfums reports April 19. Prestige product revenues were driven by the geographic rollout of Burberry Brit for Men, as well as the expanded distribution of Burberry Brit Red in both Burberry stores and select specialty stores, company adds. Sales of the new Celine Fever fragrance and the addition of the recently-acquired Nickel men's skin care business also boosted performance. Mass market sales, however, declined 16%, the firm notes. At comparable foreign currency exchange rates, net sales for Q1 grew 20%. Management also reaffirmed prior 2005 guidance, anticipating net sales will be up 19% to $280 mil. Inter Parfums will release operating results for Q1 in early May...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012998

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel